Key Lessons from Cases Worldwide - 15/08/11
Doi : 10.1016/j.amjcard.2007.02.043
Address for reprints: Li Wang, PhD, Medtronic, Inc., 7000 Central Avenue NE, Minneapolis, Minnesota 55432.Résumé |
Since OptiVol fluid status monitoring (Medtronic, Inc., Minneapolis, MN) was released to the market in 2004, the manufacturer has been working together with clinicians to better understand the operation and utility of OptiVol in a clinical setting. This has been done through completed and ongoing clinical studies and through evaluation of case studies submitted by clinicians. In the process, much has been learned about some interesting aspects of OptiVol fluid status monitoring and its use with patients with heart failure.
Le texte complet de cet article est disponible en PDF.Plan
© 2007
Elsevier Inc. Tous droits réservés.
Vol 99 - N° 10S
P. S34-S40 - mai 2007 Retour au numéro
Article précédent
- Use of Device Diagnostics as an Educational Tool to Improve Patient Adherence
- Lisa Rathman
- Collaboration Among General Cardiologists, Heart Failure Specialists, and Electrophysiologists: What Are the Barriers?
- W.H. Wilson Tang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?